Co-GP / Platform:A family office could deploy into the life sciences market by partnering with a sponsor or operator at the GP level to capitalize on the ongoing demand for specialized facilities.

Co-GP / Platform:A family office could deploy into the Boston life sciences market by backing a sponsor or operator at the GP level, focusing on co-GP or JV equity to capitalize on the sector's growth.

Co-GP / Platform:A family office could deploy into the New York City life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from a repeatable pipeline.

Co-GP / Platform:A family office could deploy into the life sciences market by backing a sponsor/operator at the GP level to share in the promote and access a pipeline of opportunities.

Co-GP / Platform:A family office could deploy into the Philadelphia life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.

Co-GP / Platform:A family office could deploy into the Boston life sciences market by partnering with a seasoned operator to co-GP on build-to-suit projects, leveraging their expertise to secure favorable terms and access to a repeatable pipeline.

Co-GP / Platform:A family office could deploy into the San Diego life science market by backing a sponsor or operator at the GP level, sharing in the promote and aligning interests for long-term value creation.

Co-GP / Platform:A family office could deploy into the Bay Area life science market by backing a sponsor or operator at the GP level, sharing in the promote and aligning interests to capitalize on the current market dislocation.

Co-GP / Platform:A family office could deploy into the Denver life sciences market by backing a sponsor/operator at the GP level to share in the promote and benefit from their expertise.

Co-GP / Platform:A family office could deploy into the Seattle life sciences market by backing a sponsor/operator at the GP level, sharing in the promote and benefiting from the growing demand for lab space.

Co-GP / Platform:A family office could deploy into the San Francisco Bay Area life sciences market by backing a sponsor or operator at the GP level, sharing in the promote and accessing a pipeline of opportunities.

Co-GP / Platform:A family office could deploy into this market by backing a life sciences operator at the GP level, sharing in the promote and benefiting from a strong pipeline of opportunities.

Co-GP / Platform:A family office could deploy into the New York life sciences market by backing a sponsor/operator at the GP level, sharing in the promote and accessing a pipeline of opportunities.

Co-GP / Platform:A family office could deploy into the Chicago life sciences market by backing a sponsor/operator at the GP level, focusing on biotherapeutics ventures to share in the promote.

Co-GP / Platform:A family office could deploy into the Philadelphia life sciences market by backing a sponsor/operator at the GP level to share in the promote and access a pipeline of opportunities.

Co-GP / Platform:A family office could deploy into the San Diego life sciences market by backing a sponsor/operator at the GP level, sharing in the promote and accessing a pipeline of projects.

Co-GP / Platform:A family office could deploy into this market by backing a life sciences operator at the GP level, sharing in the promote and gaining access to a pipeline of opportunities.

Co-GP / Platform:A family office could deploy into this market by backing a life sciences operator at the GP level, sharing in the promote and accessing a robust pipeline of opportunities.

Co-GP / Platform:A family office could deploy into this market by backing a life sciences operator at the GP level, sharing in the promote and accessing a pipeline of opportunities.

Co-GP / Platform:A family office could deploy into the Denver life sciences market by backing a sponsor/operator at the GP level, sharing in the promote and accessing a pipeline of opportunities.

Co-GP / Platform:A family office could deploy into the Boston life science sector by backing a sponsor or operator at the GP level, focusing on co-GP or JV equity to share in the promote.

Co-GP / Platform:A family office could deploy into the Bay Area life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.

Co-GP / Platform:A family office could deploy into the life sciences market by backing a specialized operator at the GP level, securing a co-GP or JV equity position to share in the promote.

Co-GP / Platform:A family office could deploy into Houston's life sciences market by backing a sponsor/operator at the GP level, capitalizing on the significant venture capital and NIH funding available.